Impacted third molar surgery.
Conditions
Interventions
Intervention 1: Groups of cases received Pergabalin 75 miligram single dose orally one hour before third molar surgery. Intervention 2: Control groups received Placebo orally one hour before third m
Treatment - Drugs
Groups of cases received Pergabalin 75 miligram single dose orally one hour before third molar surgery
Control groups received Placebo orally one hour before third molar surgery
Sponsors
Vice-Chancellery of Research and Technology, Shiraz University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 51 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria included : Older than 18 and younger than 51 years old ? ASA physical status I (without diseases) were selected ? and Exclusion criteria included: underlying disease ? Obesity (weight more than 20% above ideal weight ? Short stature (less than 140 cm) ? A history of anti-epileptic drugs or alcohol addiction ? History of allergy to opioids ? Renal dysfunction ? Nervous system diseases ? Cardiovascular diseases ? History of chronic pain and anticonvulsant drugs .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of blood pressure and heart rate. Timepoint: One hour before surgery , end of surgery and during discharge. Method of measurement: Digital blood pressure measuring device.;Measure the level of sedation. Timepoint: before surgery , end of surgery and during discharge. Method of measurement: Ramsay Sedation Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's satisfaction. Timepoint: end of surgery. Method of measurement: ranking from excellent, very good, good, average, poor.;Dentist' satisfaction from cooperation of the patient. Timepoint: end of surgery. Method of measurement: ranking from excellent, very good, good, average, poor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Reza Eftekharian
Shiraz University Of Medical Sciences
Outcome results
None listed